Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting
Abstract Background Lupus nephritis (LN) is a major cause of morbidity in childhood-onset systemic lupus erythematosus (cSLE). Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are recommended first-line induction therapies, yet comparative pediatric real-world data, particularly from Asian pop...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2026-02-01
|
| Σειρά: | BMC Rheumatology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s41927-026-00630-2 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|